biotech · Advanced Solid Tumor · Sjogren's Disease · CGEM
Cullinan Therapeutics
News and analysis for Cullinan Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Dyer St, Providence, Rhode Island 02903, US HQ
2017 Founded
7 Employees
Public company Type
CGEM · NYSE Ticker
Company details
- Status
- Public
- HQ
- Dyer St, Providence, Rhode Island 02903, US
- Founded
- 2017
- Employees
- 7
- Programs
- 16
- Drugs
- 14
- Patents
- 3
News & analysis
NovaPharmaNews articles mentioning Cullinan Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Cullinan Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.